Posts Tagged ‘research’
Inova-led study finds positive long-term health outcomes in concussion patients treated with clinical-profiles-informed care
Fairfax, VA – A new study, co-led by Inova Sports Medicine, offers encouraging news for people recovering from concussion. Published in the Journal of Head Trauma Rehabilitation, the study found that 85% of concussion patients who received clinical-profiles-informed care reported favorable long-term health-related quality of life scores one to six years after injury. Clinical-profiles-informed care…
Read MoreGroundbreaking Inova study finds potential link between long-distance running and colon cancer
Fairfax, VA – A groundbreaking new study led by Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, has revealed a potential link between extreme endurance exercise and increased risk of advanced colon cancer in younger adults, raising new questions about screening for high-performance athletes.…
Read MoreInova and the Virginia ACCESS Hub launch new study to evaluate multi-cancer detection tests
Inova, VCU, and Sentara enrolling participants in national study of blood tests designed to detect multiple cancer types Fairfax, VA – July 18, 2025 – Inova is now recruiting participants for the Vanguard Study, a national study of an innovative blood test that screens for several types of cancer. Researchers will evaluate whether these Multi-Cancer…
Read MoreInova, VCU and Sentara partner as part of new NIH research network evaluating emerging cancer screening technologies
Falls Church, VA – Three Virginia health systems together will serve as one of eight groups in the U.S. to conduct groundbreaking research for the Cancer Screening Research Network (CSRN), launched this week by the National Cancer Institute (NCI), part of the National Institutes of Health. The new clinical trials network creates a national infrastructure…
Read MoreInterested in a Career with Oncology Clinical Research?
Stephanie Van Bebber is a certified clinical research professional. She serves as the Senior Director of the Clinical Trials Office for Inova Schar Cancer Institute. We don’t need to scroll very far to see that healthcare is facing major challenges, especially in our human resources. We need more people to train and commit to careers…
Read MoreData from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases
Falls Church, VA – Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced the publication of results from a Phase 2 clinical trial evaluating the safety of fostamatinib for the treatment of hospitalized patients with COVID-19, in Clinical Infectious Diseases, an official publication of the Infectious Disease Society of America. The study was sponsored by the National…
Read MoreDiversity and Inclusion in Clinical Trials
Stephanie Van Bebber is Senior Director, Inova Schar Cancer Institute Clinical Trials Office at Inova. As we celebrate Clinical Trials Day this year, we recognize the extraordinary work that is done by research teams every day to ensure that future healthcare treatments and interventions are safe and effective. The date of May 20th honors James…
Read MoreInova’s Breast Cancer Team Takes a New Look at Hormone Therapy Treatment
A group of six Inova physicians have published a paper in the Annals of Surgical Oncology that could lead to re-thinking of treatment practices for individuals with breast cancer. The paper, published in November 2020, details the results of a systemic literature review that included over 6,000 patient cases. READ THE REPORT: Axillary Response in…
Read MoreReview of Inova COVID-19 Cases Lends Insight into Ventilator Mortality Risks
Falls Church, VA – An Inova study of COVID-19 patients sheds light on how patients have responded to advanced ICU interventions. Researchers sought to paint a realistic picture of survival expectations within a single, well-resourced healthcare system, over the patient’s entire length of stay. Christopher King, MD, transplant pulmonologist and critical care physician at Inova Fairfax…
Read MoreInova’s Dr. Aragon-Ching Part of International Team Showing Benefit of Immunotherapy in Bladder Cancer Treatment
Jeanny B. Aragon-Ching, MD of the Inova Schar Cancer Institute has co-authored a groundbreaking bladder cancer research paper just published in the New England Journal of Medicine. The large phase III clinical study showed that the addition of immunotherapy with Avelumab (Bavencio) increased the duration of overall survival by almost 50% in patients when given…
Read More